Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexter is a Poland-based healthcare company operating primarily as a pharmaceutical wholesaler and distributor of medicinal products and medical equipment. Public company descriptions indicate that it supplies products used in the diagnosis, treatment, and prevention of allergies, including products associated with allergen immunotherapy and diagnostic allergen extracts. The company appears to be commercial-stage rather than a drug developer, with its business centered on distribution and commercial supply rather than an internal clinical pipeline. Its website also highlights commercial distribution activities in veterinary nutraceuticals for horses and natural dog products under the Nexhorse and Nexpet brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexter.